𝔖 Bobbio Scriptorium
✦   LIBER   ✦

[210] EVIDENCE FOR A PATHOGENETIC ROLE OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CIRRHOTIC PORTAL HYPERTENSION

✍ Scribed by F. Vizzutti; R.G. Romanelli; U. Arena; L. Rega; M. Brogi; F. Marra; M. Foschi; R. Tarquini; G. Laffi; M. Pinzani

Book ID
117375311
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
148 KB
Volume
46
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A role for asymmetric dimethylarginine i
A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis
✍ Wim Laleman; Anita Omasta; Marc Van de Casteele; Marcel Zeegers; Ingrid Vander E πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 201 KB πŸ‘ 2 views

Reduced intrahepatic endothelial nitric oxide synthase (eNOS) activity contributes to the pathogenesis of portal hypertension (PHT) associated with cirrhosis. We evaluated whether asymmetric dimethylarginine (ADMA), a putative endogenous NOS inhibitor, may be involved in PHT associated with cirrhosi